Cas:914349-03-4 tert-butyl 3-(hydroxymethyl)-5-methylindole-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 3-(hydroxymethyl)-5-methylindole-1-carboxylate

CAS.NO:914349-03-4

Synonyms:OR1686;1-Boc-3-Hydroxymethyl-5-methylindole

Molecular Formula:C₁₅H₁₉NO₃

Molecular Weight:261.31600

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:411.5ºC at 760 mmHg

Density:1.13g/cm3

Index of Refraction:1.548

PSA:51.46000

Exact Mass:261.13600

LogP:3.22520

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like OR1686 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Boc-3-Hydroxymethyl-5-methylindole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,OR1686 Use and application,OR1686 technical grade,usp/ep/jp grade.

Related News: The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. tert-butyl 3-(hydroxymethyl)-5-methylindole-1-carboxylate manufacturer The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. tert-butyl 3-(hydroxymethyl)-5-methylindole-1-carboxylate supplier In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. tert-butyl 3-(hydroxymethyl)-5-methylindole-1-carboxylate vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. tert-butyl 3-(hydroxymethyl)-5-methylindole-1-carboxylate factory The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.